Reaction
Dental Implantation reporting signals
As of the last recalculation, Dental Implantation appears in 1,610 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is DENOSUMAB (PRR 34.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Denosumab | 409 | 34.7 | 34.7 |
| Alendronate Sodium | 163 | 23.1 | 23.2 |
| Romosozumab-Aqqg | 20 | 19.3 | 19.3 |
| Risankizumab-Rzaa | 74 | 12.2 | 12.2 |
| Upadacitinib | 71 | 11.7 | 11.7 |
| Zoledronic Acid | 28 | 9.2 | 9.2 |
| Infliximab-Dyyb | 20 | 8.9 | 9.0 |
| Raloxifene Hydrochloride | 9 | 8.0 | 8.0 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 5 | 7.5 | 7.5 |
| Sodium Oxybate | 28 | 5.6 | 5.6 |